SHA:688253 Revenue

In the year 2025, Innovita Biological Technology had annual revenue of 422.03M CNY, down -32.08%. Innovita Biological Technology had revenue of 91.63M in the quarter ending December 31, 2025, a decrease of -8.88%.

Revenue

422.03M

Revenue Growth

-32.08%

P/S Ratio

15.42

Revenue / Employee

771.54K

Employees

558

Market Cap

6.51B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	422.03M	-199.36M	-32.08%
Dec 31, 2024	621.39M	143.37M	29.99%
Dec 31, 2023	478.02M	31.40M	7.03%
Dec 31, 2022	446.62M	119.71M	36.62%
Dec 31, 2021	326.91M	-710.19M	-68.48%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Xiangxue Pharmaceutical	1.47B
R&G PharmaStudies	851.01M
Lifecome Biochemistry	502.95M
Shenzhen Weiguang Biological Products	1.27B
PharmaResources (Shanghai)	667.47M
Novogene	2.26B
Kexing Biopharm	1.53B
Wuhan Hvsen Biotechnology	1.68B

Revenue Rankings